VANGUARD GROUP INC 13D and 13G filings for RAPT Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-30 11:11 am Purchase | 2025-03-31 | 13G | RAPT THERAPEUTICS INC RAPT | VANGUARD GROUP INC | 1,034,850 6.270% | 668,300 (+182.32%) | Filing |
| 2025-02-07 5:31 pm Sale | 2025-01-31 | 13G | RAPT THERAPEUTICS INC RAPT | VANGUARD GROUP INC | 366,550 2.220% | -27,951 (-7.09%) | Filing |
| 2025-02-07 5:31 pm Sale | 2025-01-31 | 13G | RAPT THERAPEUTICS INC RAPT | VANGUARD GROUP INC | 366,550 2.220% | -27,951 (-7.09%) | Filing |
| 2024-11-12 4:59 pm Unchanged | 2024-09-30 | 13G | RAPT THERAPEUTICS INC RAPT | VANGUARD GROUP INC | 394,501 9.040% | 0 (Unchanged) | Filing |
| 2024-11-04 1:30 pm Purchase | 2024-09-30 | 13G | RAPT THERAPEUTICS INC RAPT | VANGUARD GROUP INC | 394,501 9.040% | 137,473 (+53.49%) | Filing |
| 2024-02-13 5:12 pm Purchase | 2023-12-29 | 13G | RAPT THERAPEUTICS INC RAPT | VANGUARD GROUP INC | 257,028 5.980% | 257,028 (New Position) | Filing |